The Inflammatory Bowel Disease Mediterranean Diet (IBDMED) Microbiome-targeting Nutritional Education Program
NCT05536544 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2022-09-13
Summary
The rising incidence of Crohn's disease (CD) and ulcerative colitis (UC), especially in the newly industrialized nations of Asia, highlights the possible role of environmental triggers such as diet and the gut microbiome in the pathogenesis of inflammatory bowel diseases (IBD). The Mediterranean diet (MED) has been previously correlated with beneficial outcomes in several chronic and immune-mediated diseases and has been linked with positive outcomes in IBD. However, consumption of high fiber foods like fruits, vegetables, whole grains, legumes and nuts may be challenging for patients with IBD without tight dietary guidance and support.
The IBDMED nutritional education program aims to improve the adherence of patients with IBD to MED. Patients are educated on how to implement and incorporate MED principles into their daily lifestyle, by providing information, tips, practical tools, cooking methods and recipes, that are available on an interactive website and application. Patients are monitored for their diet, sleep, physical activity and stress levels via fitness trackers and questionnaires developed for this study and receive feedback and personal recommendations from the study dietitians along the way.
This RCT will assess the feasibility and effects of an 8-week IBDMED nutritional and lifestyle education program vs. the nutritional standard of care in patients with newly diagnosed CD and in healthy subjects in Israel and India.
Conditions
- Inflammatory Bowel Diseases
Interventions
- OTHER
-
IBDMED
The IBDMED program will be applied for 8 weeks and include education on MED diet and lifestyle components, focused on increasing and diversifying dietary fiber intake, reduction of ultra-processed food intake and promoting an active lifestyle. This intervention is digitally supported by an interactive website application and step trackers to monitor lifestyle parameters.
- OTHER
-
Control
Dietary counseling according to the local dietary guidelines for patients with IBD
Sponsors & Collaborators
-
Asian Institute of Gastroenterology
collaborator UNKNOWN -
Rabin Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-05-31
- Completion
- 2024-12-31
Countries
- India
- Israel
Study Locations
More Related Trials
-
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181 ·Status: COMPLETED ·Phase: NA
-
Dietary Intervention for Inflammatory Bowel Disease Remission
NCT05920187 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Biomarker-based Multidisciplinary Team (Bio-MDT) Approach to Personalized Microbial-targeted Treatment of Pouchitis and Crohn's Disease
NCT04082559 ·Status: UNKNOWN ·Phase: NA
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
NCT06591013 ·Status: COMPLETED ·Phase: NA
-
Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease
NCT02825316 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis
NCT03053713 ·Status: COMPLETED ·Phase: NA
-
Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
NCT02335281 ·Status: UNKNOWN ·Phase: PHASE2
-
Autoimmune Protocol Diet and Inflammatory Bowel Disease
NCT03512327 ·Status: COMPLETED ·Phase: NA
-
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
NCT07343726 ·Status: NOT_YET_RECRUITING
-
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
NCT02858557 ·Status: UNKNOWN ·Phase: NA
-
Targeted Metabolomics to Decipher Dietary Contributions to Pediatric Inflammatory Bowel Disease (IBD) - Main Study
NCT05014243 ·Status: UNKNOWN
-
Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
NCT01293656 ·Status: WITHDRAWN
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Biological Therapy in Patients With Inflammatory Bowel Disease
NCT05599867 ·Status: UNKNOWN
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Dietary Modification In Inflammatory Bowel Disease Patients
NCT06871267 ·Status: RECRUITING ·Phase: NA
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease)
NCT01765998 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessing Interventions of Diet in IBD
NCT06773182 ·Status: RECRUITING ·Phase: NA
-
Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
NCT06896305 ·Status: RECRUITING ·Phase: NA
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Diet as Essential Therapy (DIET) for Inflammatory Bowel Disease
NCT03012542 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota In Children With Autoimmune Liver Disease and Its Effect on Treatment Response
NCT06183190 ·Status: COMPLETED
-
Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites
NCT03855657 ·Status: RECRUITING